Neuron Bio specializes in the development of biosolutions for the pharmaceutical and agro-food industries via its divisions: BioPharma and Bioservices.
Neuron BioPharma Division is working on the discovery and development of compounds which help to prevent or treat various neurodegenerative diseases. Research on Alzheimer’s disease is the main aim of this division, which concentrates on understanding the implications of the regulation of cholesterol in the brain. Thanks to the development of these studies Neuron Bio has become a pioneer at worldwide level in this sector and has a unique knowledge of the mechanisms that regulate cholesterol levels in the brain as well as the effects they have on the development of neurodegenerative diseases.
Neuron Bioservices division offers in vitro and in vivo assays for the discovery and evaluation of drug candidates.
On the other hand, Neuron Bio owns 50% of the company NEOL Biosolutions, S.A., (Neol) dedicated to the discovery and development of industrial bioprocess for the biofuel and chemical sector. Neol was formed from the segregation as an independent company of the former bioindustrial division of Neuron Bio. In July 2012, Repsol bought 50% of this company giving rise to an alliance that will allow accelerating the scale-up of the processes for advanced biofuels and bioplastics production previously developed by Neuron Bio.